(Date:9/8/2008)...aser scalpels, arthroscopic,surgery, genomic resea...rinary medicine is quickly expanding into new high...e benefit; it,s improving medicine for,people, too... care for their pets to,treat diseases like diabet... according to the American Veterinary Medical Asso...
(Date:9/8/2008)...zine examines Iraq and Afghanistan veterans, strug..., Washington, DC (PRWEB) S...by veterans of the Iraq and Afghanistan wars about... addiction disorders are featured in the current i...ublication of the National Council for Community B...
(Date:9/7/2008)...f older patients successfully treated for colorect...le to detect any recurrence of cancer. The study, ... , a peer-reviewed journal of the American Cancer ...monitoring of colorectal cancer survivors could af...y curative surgery for colorectal cancer have an i...
(Date:9/7/2008)... appear to lower a man,s PSA level, the blood biom...her a man is at risk of prostate cancer. , But t.... 8 in the journal Cancer , caution that men shou... prostate cancer just yet. , "We showed that me...rin and other non-steroidal anti-inflammatory drug...
Breaking Medicine News(10 mins):Health News:High-Tech Vet Medicine Saving Lives of Pets and People 2Health News:Helping Veterans in Our Communities 2Health News:Helping Veterans in Our Communities 3Health News:Many colorectal cancer survivors do not receive recommended follow-up care 2Health News:Common painkillers lower levels of prostate cancer biomarker 2(Date:9/4/2008)...n for the treatment of Acute Myeloid .... 4 /- Celator Pharmaceuticals today,... (FDA) has granted orphan,drug designation to CPX-...or the treatment of Acute Myeloid Leukemia (AML).,...ndomized Phase 2,studies with CPX-351. The first P...
(Date:9/4/2008)...al-time PCR testing for the diagnostic ...pt. 4 /- The U.S. Food & Drug,Adminis...an(R) HBV Test,the first assay for quantitating H... uses Roche,s real-time PCR technology to quantify...s blood. Doctors may use viral load,testing result...
(Date:9/4/2008)...an-Gynecologists States UFE Meets Level,A Evidence...nterventional,Radiology Treatment Is Safe, Effecti...X, Va., Sept. 4 /PRNewswire-USNewswire/ -- The Soc...ization of nearly 4,500 doctors,scientists and al...ealth,care through minimally invasive treatment in...
(Date:9/4/2008)...omen at More Than 100 Sites in the U.S., ANN ARBO...ticals, a,privately-held biopharmaceutical company...ompounds to treat endocrine, metabolic and,cardiov...tiated a second,Phase 3 clinical trial of Ophena(T...ee oral therapy in development for the treatment o...
Breaking Medicine Technology:Celator Pharmaceuticals Receives Orphan Drug Designation for Anticancer Agent CPX-351 2FDA Approves First Hepatitis B Viral Load Test 2FDA Approves First Hepatitis B Viral Load Test 3Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 2Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 3QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 2QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 3Model offers new understanding of cell signaling 15005 1Model offers new understanding of cell signaling 15005 2Spring Ankle Sprain Prevention Tips 15003 1Spring Ankle Sprain Prevention Tips 15003 2Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31 2007 15001 1Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31 2007 15001 2Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31 2007 15001 3Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31 2007 15001 4Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31 2007 15001 5Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31 2007 15001 6Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31 2007 15001 7Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31 2007 15001 8Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31 2007 15001 9Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31 2007 15001 10Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31 2007 15001 11Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31 2007 15001 12Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31 2007 15001 13Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31 2007 15001 14U S Patent Office Confirms Validity of Osteotechs U S Patent No 5 676 146 4150 1U S Patent Office Confirms Validity of Osteotechs U S Patent No 5 676 146 4150 2...roup (COG) Study Presented at,American Society of ...04, 2007 /PRNewswire-FirstCall/ -- Immunomedics,I...oping monoclonal,antibodies to treat cancer and ot...nt with epratuzumab plus standard,chemotherapy is ...cursor acute lymphoblastic leukemia (ALL), produci...
...Diatos SA, an international,biopharmaceutical comp...ercialization of targeted anti-cancer drugs, today... clinical trial of their,anti-cancer compound, DTS...ociety of Clinical Oncology (ASCO) in Chicago, USA...the targeted,treatment of several solid cancers, i...
Other Medicine Technology:Promising Results with Epratuzumab and Chemotherapy in Children,with Acute Lymphoblastic Leukemia 2Promising Results with Epratuzumab and Chemotherapy in Children,with Acute Lymphoblastic Leukemia 3Promising Results with Epratuzumab and Chemotherapy in Children,with Acute Lymphoblastic Leukemia 4Promising Results with Epratuzumab and Chemotherapy in Children,with Acute Lymphoblastic Leukemia 5Diatos Announces Positive Clinical Results for its DTS-201,Doxorubicin Prodrug Program 2Diatos Announces Positive Clinical Results for its DTS-201,Doxorubicin Prodrug Program 3Diatos Announces Positive Clinical Results for its DTS-201,Doxorubicin Prodrug Program 4Diatos Announces Positive Clinical Results for its DTS-201,Doxorubicin Prodrug Program 5The Explorer 360 and 360 Jr. catheters have a rotational connector for ease of use during procedures.
...of the PARAHISIAN catheter, combines an octapolar ...es, which permits the use of only one catheter for...is bundle electrograms. The "two catheters in one"...single venipuncture. The disadvantages of using tw...
Torqr Quadripolar Braided Shaft Fixed Curve. The Medtronic CardioRhythm Torqr Catheter is intended for use in diagnostic electrophysiologic procedures. The catheter is designed for recording intrac
Xtrem Dynamic is a line of steerable diagnosis catheters with micro handle. These catheters have been designed to provide pacing and recording during invasive electrophysiology procedures.
Medicine Products: